How did BrightSpring Health's revenue and expenses trend in Q4 2024?

BrightSpring Health's revenue and expenses in Q4 2024 showed the following trends:

1. Revenue by Business Segment: The company's revenue was distributed across various business segments, including Products, Pharmacy Solutions, Services, and Provider Services. The total revenue for the quarter was $8.75 billion.
2. Net Income: BrightSpring Health reported a net income of $15.4 million for the quarter, indicating profitability despite the revenue being spread across different business segments.
3. Operating Expenses: The company's operating expenses were not provided separately, but the Selling, General, and Administrative (SG&A) expenses were reported at $342.85 million. This suggests that the company's administrative costs were significant.
4. Research and Development (R&D) Expenses: The R&D expenses for BrightSpring Health in Q4 2024 were not provided, which could be an area to watch for future developments in their product pipeline or service innovation.

In conclusion, BrightSpring Health showed a strong revenue base with a net income, but the high SG&A expenses highlight the importance of efficient management to maintain profitability across its diverse business segments.